381 related articles for article (PubMed ID: 34041632)
1. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G
AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632
[TBL] [Abstract][Full Text] [Related]
2. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis.
Chandra A; Aggarwal G; Manchanda S; Narula A
Pharm Nanotechnol; 2019; 7(5):362-374. PubMed ID: 31490769
[TBL] [Abstract][Full Text] [Related]
3. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and
Walunj M; Doppalapudi S; Bulbake U; Khan W
J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
[TBL] [Abstract][Full Text] [Related]
5. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation.
Avasatthi V; Pawar H; Dora CP; Bansod P; Gill MS; Suresh S
Pharm Dev Technol; 2016 Aug; 21(5):554-62. PubMed ID: 26024238
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
7. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
8. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
[TBL] [Abstract][Full Text] [Related]
9. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
Katare OP; Raza K; Singh B; Dogra S
Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304
[TBL] [Abstract][Full Text] [Related]
10. An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis.
Parveen S; Ahmed M; Baboota S; Ali J
Curr Pharm Des; 2022; 28(13):1082-1102. PubMed ID: 35105284
[TBL] [Abstract][Full Text] [Related]
11. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
Amarji B; Garg NK; Singh B; Katare OP
J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326
[TBL] [Abstract][Full Text] [Related]
12. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
13. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview.
Dadwal A; Mishra N; Narang RK
Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390
[TBL] [Abstract][Full Text] [Related]
14. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches.
Rajitha P; Biswas R; Sabitha M; Jayakumar R
Curr Pharm Des; 2017; 23(24):3550-3566. PubMed ID: 28571554
[TBL] [Abstract][Full Text] [Related]
16. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S
Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459
[TBL] [Abstract][Full Text] [Related]
17. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I
Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy.
Parnami N; Garg T; Rath G; Goyal AK
Artif Cells Nanomed Biotechnol; 2014 Dec; 42(6):406-12. PubMed ID: 24079701
[TBL] [Abstract][Full Text] [Related]
19. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs
Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P
Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794
[TBL] [Abstract][Full Text] [Related]
20. Enhancing percutaneous delivery of methotrexate using different types of surfactants.
Javadzadeh Y; Hamishehkar H
Colloids Surf B Biointerfaces; 2011 Feb; 82(2):422-6. PubMed ID: 20951009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
